Albano, Luigi http://orcid.org/0000-0001-9884-0101
Agosta, Federica
Basaia, Silvia
Cividini, Camilla
Stojkovic, Tanja
Sarasso, Elisabetta http://orcid.org/0000-0002-5300-2849
Stankovic, Iva
Tomic, Aleksandra
Markovic, Vladana
Stefanova, Elka
Mortini, Pietro
Kostic, Vladimir S.
Filippi, Massimo http://orcid.org/0000-0002-5485-0479
Funding for this research was provided by:
Ministero della Salute (RF-2018-12366746)
Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja (#175090)
Article History
Received: 27 May 2021
Accepted: 10 December 2021
First Online: 10 January 2022
Competing interests
: L.A., S.B., C.C., E.S., I.S., V.M., and P.M. declare no competing interests. F.A. is Section Editor of <i>NeuroImage: Clinical</i>; received compensation for consulting services and/or speaking activities from Philips, Biogen Idec, and Roche; and receives or has received research supports from the Italian Ministry of Health, AriSLA (Fondazione Italiana di Ricerca per la SLA), and the European Research Council. T.S and E.S. have received the Alzheimer Association grant for Promoting Diversity, from 2018 and honoraria from Actavis. A.T. has received honoraria for serving as a consultant to and on the advisory board of Univar BV. V.S.K. has received speaker honoraria from Roche and Alkaloid and receives research supports from the Swiss Pharm and Serbian Ministry of Education, Science, and Development and Serbian Academy of Sciences and Art. M.F. is Editor-in-Chief of the <i>Journal of Neurology</i> and Associate Editor of <i>Human Brain Mapping</i>; received compensation for consulting services and/or speaking activities from Almirall, Alexion, Bayer, Biogen, Celgene, Eli Lilly, Genzyme, Merck-Serono, Novartis, Roche, Sanofi, Takeda, and Teva Pharmaceutical Industries; and receives research support from Biogen Idec, Merck-Serono, Novartis, Roche, Teva Pharmaceutical Industries, Italian Ministry of Health, Fondazione Italiana Sclerosi Multipla, and ARiSLA (Fondazione Italiana di Ricerca per la SLA).